Inclisiran inhibits oxidized low-density lipoprotein-induced foam cell formation in Raw264.7 macrophages via activating the PPARγ pathway
Proprotein convertase subtilisin kexin type 9 (PCSK9) is a well-known proprotein convertase that influences foam cell formation and modulates atherosclerosis. Inclisiran is a novel chemosynthetic small interfering RNA that inhibits PCSK9 synthesis. This study aimed to explore the effect of inclisira...
Main Authors: | Zhaoping Wang, Xiangyu Chen, Jingxing Liu, Yingcui Wang, Suhua Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-05-01
|
Series: | Autoimmunity |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/08916934.2022.2051142 |
Similar Items
-
Spiromastixones Inhibit Foam Cell Formation via Regulation of Cholesterol Efflux and Uptake in RAW264.7 Macrophages
by: Chongming Wu, et al.
Published: (2015-10-01) -
Determining effects of elaidic acid on PPAR- gamma expression in RAW 264.7 macrophage cell line
by: Montakhab Yegane H, et al.
Published: (2012-08-01) -
Inclisiran - hope in the fight against dyslipidemia
by: Paulina Krawiec, et al.
Published: (2023-05-01) -
Inclisiran—Silencing the Cholesterol, Speaking up the Prognosis
by: Sylwester Rogula, et al.
Published: (2021-06-01) -
Inclisiran: A New Pharmacological Approach for Hypercholesterolemia
by: Stefania Angela Di Fusco, et al.
Published: (2022-11-01)